Advertisement
Advertisement
Genesco Inc. (GCO)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 02:36PM EDT. Market open.
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 59.44 |
| Open | 61.13 |
| Bid | 62.13 x 900 |
| Ask | 62.30 x 800 |
| Day's Range | 60.93 - 62.58 |
| 52 Week Range | 48.54 - 73.72 |
| Volume | |
| Avg. Volume | 216,075 |
| Market Cap | 852.558M |
| Beta (5Y Monthly) | 1.86 |
| PE Ratio (TTM) | 8.31 |
| EPS (TTM) | 7.47 |
| Earnings Date | Aug 31, 2022 - Sep 05, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Apr 09, 1973 |
| 1y Target Est | 76.33 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
10% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for GCO
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Genesco Inc.GCO: Lowering target price to $43.00GENESCO INC has an Investment Rating of SELL; a target price of $43.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.RatingFair ValueEconomic Moatlast monthArgus Research
- Simply Wall St.
Genesco (NYSE:GCO) Shareholders Will Want The ROCE Trajectory To Continue
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
- PR Newswire
GENESCO APPOINTS GREGORY A. SANDFORT AS LEAD INDEPENDENT DIRECTOR
Genesco Inc. (NYSE: GCO) announced today that the independent directors of the Genesco Board have unanimously selected Gregory A. Sandfort as the Company's Lead Independent Director, effective June 23, 2022. Sandfort succeeds Matthew C. Diamond who has served in that role for the past four years.
- Simply Wall St.
Here's Why We Think Genesco (NYSE:GCO) Is Well Worth Watching
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
